vs
Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and TECHPRECISION CORP (TPCS). Click either name above to swap in a different company.
CRYO CELL INTERNATIONAL INC is the larger business by last-quarter revenue ($7.8M vs $7.1M, roughly 1.1× TECHPRECISION CORP). TECHPRECISION CORP runs the higher net margin — -20.8% vs -48.7%, a 27.9% gap on every dollar of revenue. On growth, CRYO CELL INTERNATIONAL INC posted the faster year-over-year revenue change (-2.3% vs -6.9%). CRYO CELL INTERNATIONAL INC produced more free cash flow last quarter ($1.2M vs $-827.0K). Over the past eight quarters, CRYO CELL INTERNATIONAL INC's revenue compounded faster (-0.1% CAGR vs -9.2%).
Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.
TechPrecision Corp is a manufacturer of custom high-precision metal fabricated components and integrated systems, serving aerospace, defense, medical technology, renewable energy, and industrial end markets primarily across North America and Europe. It specializes in producing tight-tolerance, mission-critical parts that adhere to rigorous industry quality requirements.
CCEL vs TPCS — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $7.8M | $7.1M |
| Net Profit | $-3.8M | $-1.5M |
| Gross Margin | 77.9% | 5.4% |
| Operating Margin | -50.6% | -19.1% |
| Net Margin | -48.7% | -20.8% |
| Revenue YoY | -2.3% | -6.9% |
| Net Profit YoY | -105.1% | -84.4% |
| EPS (diluted) | $-0.46 | $-0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.8M | $7.1M | ||
| Q3 25 | $7.8M | $9.1M | ||
| Q2 25 | $7.9M | $7.4M | ||
| Q1 25 | $8.0M | $9.5M | ||
| Q4 24 | $8.0M | $7.6M | ||
| Q3 24 | $8.1M | $8.9M | ||
| Q2 24 | $8.0M | $8.0M | ||
| Q1 24 | $7.9M | $8.6M |
| Q4 25 | $-3.8M | $-1.5M | ||
| Q3 25 | $749.4K | $825.0K | ||
| Q2 25 | $355.8K | $-597.0K | ||
| Q1 25 | $282.9K | $112.0K | ||
| Q4 24 | $-1.9M | $-799.0K | ||
| Q3 24 | $1.1M | $-601.0K | ||
| Q2 24 | $655.8K | $-1.5M | ||
| Q1 24 | $556.2K | $-5.1M |
| Q4 25 | 77.9% | 5.4% | ||
| Q3 25 | 77.0% | 27.1% | ||
| Q2 25 | 76.6% | 14.0% | ||
| Q1 25 | 75.1% | 22.0% | ||
| Q4 24 | 78.4% | 13.0% | ||
| Q3 24 | 73.6% | 11.3% | ||
| Q2 24 | 74.8% | 3.0% | ||
| Q1 24 | 73.7% | 14.3% |
| Q4 25 | -50.6% | -19.1% | ||
| Q3 25 | 24.3% | 10.4% | ||
| Q2 25 | 18.8% | -6.3% | ||
| Q1 25 | 13.3% | 3.9% | ||
| Q4 24 | -1.5% | -9.1% | ||
| Q3 24 | 17.2% | -5.5% | ||
| Q2 24 | 17.3% | -16.8% | ||
| Q1 24 | 10.5% | -28.6% |
| Q4 25 | -48.7% | -20.8% | ||
| Q3 25 | 9.6% | 9.1% | ||
| Q2 25 | 4.5% | -8.1% | ||
| Q1 25 | 3.5% | 1.2% | ||
| Q4 24 | -23.2% | -10.5% | ||
| Q3 24 | 13.0% | -6.7% | ||
| Q2 24 | 8.2% | -18.3% | ||
| Q1 24 | 7.1% | -59.5% |
| Q4 25 | $-0.46 | $-0.15 | ||
| Q3 25 | $0.09 | $0.08 | ||
| Q2 25 | $0.04 | $-0.06 | ||
| Q1 25 | $0.03 | $0.01 | ||
| Q4 24 | $-0.23 | $-0.08 | ||
| Q3 24 | $0.13 | $-0.06 | ||
| Q2 24 | $0.08 | $-0.16 | ||
| Q1 24 | $0.07 | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.3M | $50.0K |
| Total DebtLower is stronger | $8.4M | — |
| Stockholders' EquityBook value | $-18.6M | $8.0M |
| Total Assets | $61.7M | $32.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.3M | $50.0K | ||
| Q3 25 | $3.2M | $220.0K | ||
| Q2 25 | $4.4M | $143.0K | ||
| Q1 25 | $3.5M | $195.0K | ||
| Q4 24 | $3.5M | $165.0K | ||
| Q3 24 | $2.1M | $132.0K | ||
| Q2 24 | $1.5M | $44.8K | ||
| Q1 24 | $979.6K | $138.0K |
| Q4 25 | $8.4M | — | ||
| Q3 25 | $8.4M | — | ||
| Q2 25 | $8.4M | — | ||
| Q1 25 | $8.5M | $3.0K | ||
| Q4 24 | $8.5M | $19.0K | ||
| Q3 24 | $8.5M | — | ||
| Q2 24 | $8.5M | — | ||
| Q1 24 | $8.6M | — |
| Q4 25 | $-18.6M | $8.0M | ||
| Q3 25 | $-14.8M | $9.1M | ||
| Q2 25 | $-15.6M | $8.2M | ||
| Q1 25 | $-14.7M | $8.7M | ||
| Q4 24 | $-13.2M | $8.1M | ||
| Q3 24 | $-9.6M | $8.9M | ||
| Q2 24 | $-10.7M | $7.9M | ||
| Q1 24 | $-10.3M | $7.8M |
| Q4 25 | $61.7M | $32.8M | ||
| Q3 25 | $63.2M | $33.8M | ||
| Q2 25 | $64.4M | $32.1M | ||
| Q1 25 | $64.4M | $33.5M | ||
| Q4 24 | $64.7M | $32.2M | ||
| Q3 24 | $62.9M | $35.0M | ||
| Q2 24 | $62.6M | $35.7M | ||
| Q1 24 | $61.7M | $34.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.3M | $183.0K |
| Free Cash FlowOCF − Capex | $1.2M | $-827.0K |
| FCF MarginFCF / Revenue | 15.5% | -11.7% |
| Capex IntensityCapex / Revenue | 0.9% | 14.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $5.2M | $-4.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.3M | $183.0K | ||
| Q3 25 | $2.5M | $-1.1M | ||
| Q2 25 | $707.0K | $646.0K | ||
| Q1 25 | $954.1K | $396.0K | ||
| Q4 24 | $2.2M | $-570.0K | ||
| Q3 24 | $2.4M | $-532.0K | ||
| Q2 24 | $1.8M | $107.0K | ||
| Q1 24 | $-356.9K | $-452.0K |
| Q4 25 | $1.2M | $-827.0K | ||
| Q3 25 | $2.5M | $-2.1M | ||
| Q2 25 | $644.6K | $-604.0K | ||
| Q1 25 | $892.0K | $-930.0K | ||
| Q4 24 | $2.1M | $-1.7M | ||
| Q3 24 | $2.3M | $-2.0M | ||
| Q2 24 | $21.5K | $-94.0K | ||
| Q1 24 | $-814.6K | $-900.0K |
| Q4 25 | 15.5% | -11.7% | ||
| Q3 25 | 31.9% | -22.9% | ||
| Q2 25 | 8.1% | -8.2% | ||
| Q1 25 | 11.2% | -9.8% | ||
| Q4 24 | 26.8% | -22.9% | ||
| Q3 24 | 27.9% | -21.8% | ||
| Q2 24 | 0.3% | -1.2% | ||
| Q1 24 | -10.4% | -10.5% |
| Q4 25 | 0.9% | 14.2% | ||
| Q3 25 | 0.5% | 11.0% | ||
| Q2 25 | 0.8% | 16.9% | ||
| Q1 25 | 0.8% | 14.0% | ||
| Q4 24 | 0.1% | 15.4% | ||
| Q3 24 | 2.3% | 15.9% | ||
| Q2 24 | 21.8% | 2.5% | ||
| Q1 24 | 5.8% | 5.2% |
| Q4 25 | — | — | ||
| Q3 25 | 3.38× | -1.31× | ||
| Q2 25 | 1.99× | — | ||
| Q1 25 | 3.37× | 3.54× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.32× | — | ||
| Q2 24 | 2.70× | — | ||
| Q1 24 | -0.64× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCEL
Segment breakdown not available.
TPCS
| Defense | $6.7M | 94% |
| Other | $410.0K | 6% |
